OA01.05LB Opening the HIV-1 envelope for neutralization and antibody-dependent cellular cytotoxicityOral Abstract SessionTherapeutic vaccines, viral reservoirs and eradication/remission
OA14.01 Improved killing of HIV-infected cells by a combination of three neutralizing and non-neutralizing antibodiesOral Abstract SessionTherapeutic vaccines, viral reservoirs and eradication/remission
OA14.02 Unprimed CD8+ lymphocytes promote the maintenance of HIV latency in CD4+ T cellsOral Abstract SessionTherapeutic vaccines, viral reservoirs and eradication/remission
OA14.04 Targeting Sphingosine-1-phosphate signaling prevents cell-to-cell transmission of HIV-1Oral Abstract SessionTherapeutic vaccines, viral reservoirs and eradication/remission
PE26.01 Surge strategies improve HIV testing efficiency and linkage to treatment among female sex workers in Nairobi, KenyaE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE26.02 Effect of a novel HIV-1 RNA testing intervention to detect acute and prevalent HIV infection in young adults and reduce HIV transmission in Kenya: A randomized controlled trialE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.01 Association between Basal Metabolic Index and vaccine-induced HIV-1 adaptive immunityE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.02 The influence of HIV-1 subtype C LTR genotype on latency potentialE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.03 Impact of baseline variables on time to viral rebound after treatment interruption in acutely treated HIV-1 infected participantsE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PU28.01 Findings from an HIV risk behavior assessment among penal and probation population in Ukraine  Publication OnlyTherapeutic vaccines, viral reservoirs and eradication/remission
seek-warrow-warrow-eseek-e21 - 30 of 444 items